Menopause in Female Athletes: What the Science Says About Performance, Physiology, and Training Adaptation
Table of Contents
Key Takeaways: Menopause in Female Athletes
- Menopause in female athletes is not only a reproductive transition. It can affect bone health, muscle strength, cardiovascular risk, sleep quality, recovery, and training adaptation.
- Female athletes are not immune to menopausal symptoms. Research suggests that symptom burden may be similar to that seen in the general population despite high levels of physical activity.
- Sleep disturbance is one of the most clinically significant symptoms because it can affect recovery, motivation, training consistency, mood, and overall quality of life.
- Declining oestrogen levels contribute to losses in bone mineral density and muscle strength, making musculoskeletal health an important consideration during and after the menopause transition.
- Resistance training plays an important role in preserving muscle mass, strength, functional capacity, and long-term independence.
- Aerobic exercise remains valuable for cardiovascular health, particularly as cardiovascular risk factors become more relevant after menopause.
- Bone health should not be viewed only through the lens of athletic performance. Maintaining skeletal strength may influence mobility, independence, and fracture risk later in life.
- Menopause is primarily a clinical diagnosis. In Finnish clinical practice, evaluation often begins with age, symptoms, and menstrual history rather than laboratory testing alone.
- Menopausal hormone therapy may be considered in appropriate patients as part of an individualized management strategy, taking symptoms, benefits, and risks into account.
- Menopause is not the end of athletic participation. With appropriate adaptation and long-term attention to health, many women can continue training, competing, and remaining physically active well beyond the menopause transition.
Introduction: Menopause in Female Athletes
There is a moment that many female athletes describe in strikingly similar terms: the training load has not changed, recovery feels harder, sleep is fragmenting, joints ache in ways they never used to, and the performance ceiling that once felt limitless now seems to fluctuate week to week.
This can be especially confusing because menopause is not always viewed as a sports medicine issue. Sport is often associated with youth, and by the time many women reach midlife, their relationship with training or competition may have changed. But some women are still training seriously, competing, or performing at a high level when the menopause transition begins.
For athletes in their mid-40s, this is not necessarily a training problem. It may be a physiology problem — and one that remains underrecognised in sports medicine. The menopause transition (perimenopause) is a biological process that, on average, spans 2–8 years before the final menstrual period and is associated with an increase in clinical and subclinical physiological changes and risks [7][12]. For female athletes, the menopause transition does not pause competition schedules or training blocks. It unfolds in the middle of them.
In my view, sport should not be seen as something that ends with youth. If anything, physical activity can become even more important after midlife, when maintaining strength, mobility, bone health, recovery capacity, and general health becomes increasingly relevant. This is why the menopause transition deserves attention in female athletes: not because every symptom is caused by hormones, and not because every athlete will experience the transition in the same way, but because this life stage can meaningfully change how the body responds to training, recovery, and everyday physical stress.
What Is Menopause in Female Athletes?
Perimenopause — formally the menopausal transition — begins with the onset of menstrual irregularities in the later reproductive years and extends until one year after the final menstrual period. The core physiological driver is the progressive depletion of ovarian follicles, which causes oestradiol levels to fall and follicle-stimulating hormone (FSH) to rise [12].
This hormonal shift is not simply a reproductive event. Oestrogen receptors are distributed throughout skeletal muscle, bone, connective tissue, the cardiovascular system, and the central nervous system [4]. When oestradiol declines during the menopause transition, many of the physiological systems relevant to athletic performance are affected.
The clinical picture is broader than most coaches and even many sports medicine practitioners appreciate. In a 2024 landmark review published in Climacteric, Wright and colleagues introduced the term “musculoskeletal syndrome of menopause” to describe the collective musculoskeletal signs and symptoms associated with the loss of oestrogen — a syndrome that includes arthralgia, loss of muscle mass, loss of bone density, and progression of osteoarthritis [4]. More than 70% of women will experience musculoskeletal symptoms through the menopause transition from perimenopause to postmenopause, and 25% will be disabled by them [4].
In traditional clinical practice, menopause is often framed through symptoms such as hot flushes, insomnia, mood changes, and genitourinary symptoms. These are important, but they do not capture the whole picture for an athlete. From a sports medicine perspective, the menopause transition can also affect the systems that make training possible in the first place: the musculoskeletal system, the cardiovascular system, and the nervous system.
In my view, this is where the impact on athletes can become especially relevant. Joint pain, changes in muscle strength, altered recovery, reduced training tolerance, sleep disruption, and changes in cardiovascular risk do not only affect comfort or general well-being. They can also change how an athlete tolerates load, adapts to training, and maintains performance over time. In practice, this is why menopause should not be viewed only as a reproductive or symptom-management issue, but also as a broader physiological transition that can affect athletic capacity.
Menopause in Female Athletes: Symptom Prevalence
A critical assumption has long persisted in sports medicine: that high physical activity levels protect female athletes from menopausal symptoms. A 2025 study in PLOS ONE challenges this assumption directly.
Hamilton and colleagues recruited 187 female endurance athletes (runners, cyclists, swimmers, and triathletes) aged 40–60 years and assessed menopausal symptom frequency and its perceived effect on training and performance. The most commonly reported menopausal symptoms were sleep problems (88%), physical and mental exhaustion (83%), sexual problems (74%), anxiety (72%), irritability (68%), depressive mood (67%), weight gain (67%), hot flushes (65%), and joint and muscular discomfort (63%) [1].
Crucially, the symptoms that were perceived to most negatively affect training and performance were joint and muscular discomfort, weight gain, sleep problems, and physical and mental exhaustion [1]. In the paper’s summary: “frequency of menopausal symptoms among female endurance athletes is high and severity of menopausal symptoms is similar to that reported in the general population” [1].
This is a clinically important finding. Physical fitness does not confer immunity from the menopause transition. Despite training volumes that far exceed those of the general population, female athletes experience the same symptom burden — they are simply less likely to have it recognised and addressed in a sports medicine context.
Clinicians are not concerned only with the symptoms themselves. Poor sleep, mood symptoms, vasomotor symptoms, and musculoskeletal discomfort can also make it harder to maintain motivation, eat well, train consistently, and sustain the healthy routines that normally protect long-term health. In practice, this is often where the menopause transition becomes clinically important: the symptoms do not occur in isolation, but can begin to affect the behaviours that support recovery, body composition, and performance.
From a clinical perspective, there are also broader physiological concerns. Loss of muscle mass, increasing cardiovascular risk, and changes in fat distribution can become more relevant during and after the menopause transition. This is one reason why exercise may become even more important at this stage of life, not less. In my view, many women can compensate well physiologically before menopause, but the transition can make the margin for error smaller. When sleep, recovery, training consistency, and nutrition begin to suffer at the same time, the body may become less forgiving than it used to be.
How Menopause in Female Athletes Affects Performance
Understanding the mechanism is essential for rational clinical management of menopause in female athletes.
Bone mineral density. During perimenopause, women have an average reduction of 10% in bone mineral density [4]. As oestrogen levels reduce during the menopausal transition, there is greater bone resorption than bone formation, resulting in decreased BMD and risk of osteoporotic fractures [3]. For athletes training under high mechanical loads — particularly those in endurance, impact, and combat sports — the combination of declining BMD and oestrogen-driven changes in tendon and ligament elasticity may increase stress fracture and soft tissue injury risk.
From a clinical perspective, this is not an abstract concern. In older women, fragility fractures are something clinicians encounter regularly, especially wrist fractures after a fall and hip fractures after slipping or losing balance. I would not use these older fracture patterns as a direct model for younger menopausal athletes, but they do show why bone health cannot be treated as a secondary issue. For female athletes approaching the menopause transition, exercise is not only about performance. It can also be part of preserving the musculoskeletal reserve that may matter decades later.
Muscle mass and strength. The menopause transition accelerates a process that began earlier: the progressive loss of skeletal muscle mass. Women have a reduction of 0.6% in muscle mass per year after menopause [4]. At the tissue level, oestradiol plays a direct role in muscle protein synthesis and in maintaining the sensitivity of muscle to anabolic stimuli [4]. A longitudinal study by Bondarev and colleagues from the University of Jyväskylä followed women from the general population prospectively through the menopausal transition and found a significant decline in handgrip force (−2.1%, 95% CI −3.8 to −0.4), knee extension torque (−2.6%, 95% CI −4.5 to −0.8), and vertical jumping height (−2.6%, 95% CI −4.2 to −1.1) [2]. While this data comes from a general population cohort, the magnitude of these declines illustrates the physiological headwinds that transitioning athletes face at the tissue level.
In clinical practice, some women describe a noticeable loss of muscle strength and training capacity after the menopause transition. This is not only about performance: over time, reduced muscle mass and strength can affect everyday function, such as rising from a chair, climbing stairs, maintaining balance, or walking confidently. Menopause is rarely the only factor, as ageing, inactivity, nutrition, illness, pain, medications, and previous injuries can also contribute. Still, for athletes, the key message is clear: preserving muscle mass and strength supports not only performance, but also long-term independence and physical function.
Cardiovascular fitness. The menopausal transition period spans, on average, 2–8 years before the final menstrual period and is associated with an increase in clinical and subclinical cardiovascular risk [7]. Adverse metabolic changes include dyslipidaemia, increased abdominal adiposity, insulin resistance, and endothelial dysfunction — all of which can compromise cardiorespiratory reserve. A 2025 meta-analysis examining 78 randomised controlled trials with 5,332 midlife women found that exercise interventions produced a favourable effect on VO2max versus control (3.51 mL/kg/min, 95% CI 2.75 to 4.27) [8]. Although this meta-analysis focused primarily on the general population, it underscores the potent cardiovascular benefit of structured exercise during this lifecycle stage.
In my clinical experience, cardiovascular risk is often considered as part of the overall assessment in postmenopausal women rather than as an isolated issue. Even in active individuals, cardiovascular health remains one component of the broader clinical picture, alongside physical function, body composition, symptoms, and general health.
Sleep and recovery. Sleep disturbance is one of the most common and debilitating symptoms experienced by women during the menopause transition [5]. Vasomotor symptoms — hot flushes and night sweats — fragment sleep architecture, reducing restorative sleep duration and quality. For athletes, this carries direct physiological costs: research demonstrates that acute sleep deprivation reduces muscle protein synthesis by 18% [10], and chronic sleep fragmentation is generally understood in sports science to impair overnight hormonal recovery and substrate repletion. In the context of menopause in female athletes, where vasomotor-driven sleep disruption may persist across months or years, these recovery deficits compound progressively over training cycles.
Sleep problems are often among the most disruptive symptoms in the menopause transition. In my clinical experience, many women can tolerate a certain amount of joint discomfort, hot flushes, or changes in training capacity, but persistent poor sleep can affect almost every part of daily life. It can reduce motivation, make training feel harder, worsen recovery, and make other symptoms more difficult to manage.
For athletes, this matters because sleep is not just rest; it is part of the adaptation process. When sleep becomes fragmented for weeks or months, the problem is no longer limited to tiredness. It can begin to affect consistency, mood, training quality, and the ability to recover from normal physical stress. In practice, sleep is often the symptom that finally makes the menopause transition feel clinically significant.
Evidence-Based Solutions for Menopause in Female Athletes
Management of menopause in female athletes operates across two complementary layers: lifestyle modification (exercise, nutrition, sleep) and pharmacological intervention (menopausal hormone therapy, where appropriate). Both require individualisation.
Resistance Training: Non-Negotiable
Resistance training is a central evidence-supported intervention for mitigating musculoskeletal decline during the menopause transition. Resistance training is recommended for post-menopausal women specifically to counteract sarcopenia and maintain functional strength capacity [6]. A 2025 scoping review found that resistance training completed 2–3 days per week at a moderate-to-high intensity combined with impact activity completed at a minimum of 3 days per week is optimal for improving BMD in menopausal women [3].
For competitive athletes, this means the training programme must maintain or increase its resistance training volume through the transition — not reduce it. A common error is to pull back on strength work when athletes report joint discomfort or fatigue, when in fact the opposite adaptation is required. Loading the musculoskeletal system appropriately — with progressive overload, adequate recovery, and monitored training volume — remains the primary intervention.
For older women in particular, resistance training becomes increasingly relevant because muscle strength is often one of the main factors that determines physical independence later in life. When strength declines far enough, mobility can begin to narrow: first through difficulty rising from a chair, climbing stairs, or walking longer distances, and later through a broader loss of confidence and functional capacity.
In my clinical experience, this loss of mobility can have one of the greatest effects on overall quality of life. For athletes, the message is not only that strength training may help preserve performance, but that maintaining muscle strength is also part of protecting long-term health, independence, and everyday freedom.
Aerobic Exercise and Vasomotor Symptoms
Exercise also has a direct effect on the vasomotor symptoms that drive sleep disruption and perceived fatigue in menopause in female athletes. A 2022 systematic review and meta-analysis appraising 21 RCTs involving 2,884 participants found that compared to no-treatment control, exercise significantly improved severity of vasomotor symptoms (10 studies, SMD = 0.25; 95% CI: 0.04 to 0.47, p = 0.02) [9]. The magnitude of effect is modest, and exercise does not eliminate hot flushes. However, in an athletic population already training regularly, structured aerobic work should be understood as actively managing — not ignoring — vasomotor symptom burden.
For ageing women in particular, aerobic exercise has an important role in supporting cardiovascular health. While it may also help maintain general fitness and endurance, I see its greatest value in helping offset some of the cardiovascular risks that become increasingly relevant with age.
Nutrition: Protein and Bone-Protective Nutrients
Observational and interventional studies suggest post-menopausal females should ingest at least the RDA 0.8 g·kg⁻¹·d⁻¹ of protein [6]. For active athletes, this threshold substantially underestimates actual requirements; most sports nutrition experts suggest higher intakes to support muscle protein synthesis and blunt estrogen-deficiency-related anabolic resistance.
Calcium intake (1,000–1,200 mg daily from food sources where possible) and adequate vitamin D status are essential adjuncts to bone-protective exercise [3]. These nutritional foundations must be secured before other interventions are layered on top.
Menopausal Hormone Therapy: A Clinical Tool, Not a Last Resort
Combining MHT with exercise enhances BMD more than either alone [3]. This represents a clinically important evidence base for menopause in female athletes: MHT is not merely a symptomatic treatment but an active component of musculoskeletal preservation strategy during the menopause transition. The decision to initiate MHT requires individual risk-benefit analysis — particularly regarding cardiovascular history, thromboembolism risk, and breast cancer risk — and should be made in collaboration with a clinician experienced in women’s health and sports medicine.
At least in Finnish clinical practice, menopausal symptoms are often managed based on the overall clinical picture rather than laboratory testing alone. When the age, menstrual history, and symptom pattern are typical, treatment may sometimes be started in primary care without specialist consultation or extensive laboratory evaluation. This approach is also reflected in the Finnish Current Care Guideline [11], which emphasises that menopause is primarily a clinical diagnosis. From my perspective, this is an important distinction for athletes as well: the menopause transition is not always a laboratory diagnosis. In many cases, the clinical history is the central starting point.
Conclusion: Menopause in Female Athletes
Menopause in female athletes is often discussed through the lens of symptoms, but from a clinical perspective its effects extend much further. The menopause transition can influence bone health, muscle strength, cardiovascular risk, sleep quality, recovery, and ultimately an athlete’s ability to train consistently over time. While these changes can be challenging, they should not be viewed as a reason to stop exercising or competing.
In many ways, the opposite may be true. In my view, the importance of exercise often becomes even greater during and after the menopause transition. Resistance training helps preserve muscle mass, strength, and physical independence, while aerobic exercise remains an important component of cardiovascular health. Sleep, nutrition, and overall lifestyle habits also become increasingly relevant when the physiological margin for error becomes smaller.
Perhaps the most important message is that menopause is not the end of athletic participation. It is a normal biological transition that deserves the same attention and understanding as any other factor that affects training, recovery, and long-term health. Female athletes who recognise these changes, adapt appropriately, and continue investing in their physical health can remain active, capable, and competitive for many years beyond the menopause transition.
Bibliography
[1] https://doi.org/10.1371/journal.pone.0335738
[2] https://doi.org/10.1093/gerona/glaa292
[3] https://doi.org/10.3389/frph.2025.1542746
[4] https://doi.org/10.1080/13697137.2024.2380363
[5] https://doi.org/10.1097/GME.0000000000002386
[6] https://doi.org/10.3390/physiologia4030016
[7] https://doi.org/10.1038/s41569-023-00926-7
[8] https://doi.org/10.1007/s42978-025-00343-x
[9] https://doi.org/10.1080/13697137.2022.2097865
[10] https://doi.org/10.14814/phy2.14660
